Keyphrases
Neurotransmitter Systems
100%
Pathophysiologic
100%
Scoping Review
100%
Premature Ejaculation
100%
Pharmaceutics
36%
Genetic Association
18%
Serotonergic
18%
Serotonergic System
18%
Phosphodiesterase Type 5 Inhibitors
18%
Polymorphism
9%
Meta-analysis
9%
Genetic Association Studies
9%
Genome-wide Association Study
9%
Neurotransmitters
9%
Genetic Research
9%
Dopamine
9%
Genetic Studies
9%
Selective Serotonin Reuptake Inhibitors
9%
Serotonin
9%
Treatment Study
9%
Predisposing Factors
9%
Pharmacotherapy
9%
Systematic Meta-analysis
9%
Reporting Item
9%
Multi-target
9%
Spontaneous Excitatory Postsynaptic Current (sEPSC)
9%
Serotonin Transporter
9%
Vardenafil
9%
Text Reviews
9%
Citation Tracking
9%
High Efficacy
9%
Deduplication
9%
Serotonergic Drugs
9%
Open Science Framework
9%
Tadalafil
9%
PRISMA-ScR
9%
Successful Treatment
9%
INIS
reviews
100%
men
100%
genetics
77%
serotonin
33%
phosphodiesterases
22%
screening
11%
drugs
11%
tools
11%
dopamine
11%
receptors
11%
yields
11%
design
11%
enzymes
11%
antidepressants
11%
norepinephrine
11%
pharmacotherapy
11%
Medicine and Dentistry
Premature Ejaculation
100%
Neurotransmitter
100%
Genetic Association
27%
Meta-Analysis
9%
Systematic Review
9%
Drug Therapy
9%
Genome Wide Association Study
9%
Disease Predisposition
9%
Noradrenalin
9%
Phosphodiesterase V Inhibitor
9%
Selective Serotonin Reuptake Inhibitor
9%
Serotonin
9%
Phosphodiesterase V
9%
Genetic Research
9%
Vardenafil
9%
Serotonin Transporter
9%
Serotonin Receptor
9%
Tadalafil
9%
Antidepressant
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neurotransmitter
100%
Premature Ejaculation
100%
Serotonin
9%
Antidepressant
9%
Pharmacotherapy
9%
Disease Predisposition
9%
Noradrenalin
9%
Vardenafil
9%
Phosphodiesterase V Inhibitor
9%
Phosphodiesterase V
9%
Serotonin Transporter
9%
Selective Serotonin Reuptake Inhibitor
9%
Tadalafil
9%
Serotonin Receptor
9%